221 related articles for article (PubMed ID: 32737729)
21. Second primary tumors in patients with retinoblastoma. A review of the literature.
Moll AC; Imhof SM; Bouter LM; Tan KE
Ophthalmic Genet; 1997 Mar; 18(1):27-34. PubMed ID: 9134547
[TBL] [Abstract][Full Text] [Related]
22. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis.
Jiménez I; Laé M; Tanguy ML; Savignoni A; Gauthier-Villars M; Desjardins L; Cassoux N; Dendale R; Rodriguez J; Doz F; Brisse HJ; Aerts I
Pediatr Blood Cancer; 2020 Apr; 67(4):e28158. PubMed ID: 31904159
[TBL] [Abstract][Full Text] [Related]
23. NEWLY DIAGNOSED ACTIVE RETINOBLASTOMA IN ADULTS.
Kaliki S; Shields CL; Gupta A; Mishra DK; Das C; Say EA; Shields JA
Retina; 2015 Dec; 35(12):2483-8. PubMed ID: 26035399
[TBL] [Abstract][Full Text] [Related]
24. Ewing's sarcoma as second malignant neoplasm after retinoblastoma: a case report.
Mittal R; Al Awadi S; Sahar O; Behbehani AM
Med Princ Pract; 2008; 17(1):84-5. PubMed ID: 18059108
[TBL] [Abstract][Full Text] [Related]
25. The management of retinoblastoma.
Fabian ID; Onadim Z; Karaa E; Duncan C; Chowdhury T; Scheimberg I; Ohnuma SI; Reddy MA; Sagoo MS
Oncogene; 2018 Mar; 37(12):1551-1560. PubMed ID: 29321667
[TBL] [Abstract][Full Text] [Related]
26. Asynchronous bilateral retinoblastoma: the St. Jude Children's Research Hospital experience.
Fontanesi J; Pratt C; Meyer D; Elverbig J; Parham D; Kaste S
Ophthalmic Genet; 1995 Sep; 16(3):109-12. PubMed ID: 8556279
[TBL] [Abstract][Full Text] [Related]
27. Second primary osteosarcomas in patients with retinoblastoma.
Fujiwara T; Fujiwara M; Numoto K; Ogura K; Yoshida A; Yonemoto T; Suzuki S; Kawai A
Jpn J Clin Oncol; 2015 Dec; 45(12):1139-45. PubMed ID: 26438540
[TBL] [Abstract][Full Text] [Related]
28. Clinical course of retinoblastoma.
Islam F; Zafar SN; Siddiqui SN; Khan A
J Coll Physicians Surg Pak; 2013 Aug; 23(8):566-9. PubMed ID: 23930873
[TBL] [Abstract][Full Text] [Related]
29. Phthisis bulbi in retinoblastoma.
Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Bajaj MS; Chawla B; Sethi S; Ghose S; Chandra M
Clin Exp Ophthalmol; 2011 Mar; 39(2):105-10. PubMed ID: 21040312
[TBL] [Abstract][Full Text] [Related]
30. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update.
Friedman DN; Hsu M; Moskowitz CS; Francis JH; Lis E; Fleischut MH; Oeffinger KC; Walsh M; Tonorezos ES; Sklar CA; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2020 Jul; 67(7):e28389. PubMed ID: 32386119
[TBL] [Abstract][Full Text] [Related]
31. Orbital growth retardation in retinoblastoma survivors: work in progress.
Peylan-Ramu N; Bin-Nun A; Skleir-Levy M; Bibas A; Koplewitz B; Anteby I; Pe'er J
Med Pediatr Oncol; 2001 Nov; 37(5):465-70. PubMed ID: 11745876
[TBL] [Abstract][Full Text] [Related]
32. [ADVANCES IN THE TREATMENT OF RETINOBLASTOMA AT HADASSAH IN THE LAST THREE DECADES].
Frenkel S; Weintraub M; Rot I; Shoshani N; Pe'er J
Harefuah; 2018 Mar; 157(3):149-153. PubMed ID: 29582943
[TBL] [Abstract][Full Text] [Related]
33. Strabismus in retinoblastoma survivors with long-term follow-up.
Fabian ID; Stacey AW; Naeem Z; Onadim Z; Chowdhury T; Duncan C; Sagoo MS; Reddy MA
J AAPOS; 2018 Aug; 22(4):276.e1-276.e7. PubMed ID: 30009948
[TBL] [Abstract][Full Text] [Related]
34. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
[TBL] [Abstract][Full Text] [Related]
35. A 20-year audit of retinoblastoma treatment outcomes.
Gündüz AK; Mirzayev I; Temel E; Ünal E; Taçyıldız N; Dinçaslan H; Köse SK; Özalp Ateş FS; Işık MU
Eye (Lond); 2020 Oct; 34(10):1916-1924. PubMed ID: 32376976
[TBL] [Abstract][Full Text] [Related]
36. Study on clinical therapeutic effect including symptoms, eye preservation rate, and follow-up of 684 children with retinoblastoma.
Huang D; Zhang Y; Zhang W; Wang Y; Zhang P; Hong L; Zhou Y; Han T; Zhi T
Eur J Ophthalmol; 2013; 23(4):532-8. PubMed ID: 23483499
[TBL] [Abstract][Full Text] [Related]
37. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
38. Management of massive orbital involvement of intraocular retinoblastoma.
Kiratli H; Bilgiç S; Ozerdem U
Ophthalmology; 1998 Feb; 105(2):322-6. PubMed ID: 9479294
[TBL] [Abstract][Full Text] [Related]
39. Neonatal neoplasms.
Halperin EC
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):171-8. PubMed ID: 10758320
[TBL] [Abstract][Full Text] [Related]
40. Management and outcome of unilateral retinoblastoma.
Mallipatna AC; Sutherland JE; Gallie BL; Chan H; Héon E
J AAPOS; 2009 Dec; 13(6):546-50. PubMed ID: 20006813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
